glp-1 receptor antagonist Emerging Nondopaminergic Medications for Parkinson's Disease: Focusing on A2A Antagonists and GLP1 Receptor Agonists Frontiers | Clinical perspectives on

Recent research suggests GLP-1 therapy may help

Similar content being viewed by others Background Type 2 diabetes (T2D) is characterized by hyperglycemia, reduced insulin secretion, and insulin resistance [1]

As a dietitian, I usually recommend aiming for about 0.7 grams of protein per pound of body weight per day as a starting point (thats around 105 grams daily if you weigh 150 pounds)

If you're curious whether a GLP-1 is right for you, or you want to address a change you've already noticed, start a consultation and we'll build a plan around your goals

How GLP-1 Drugs Cause It: Slowing effect extends beyond the stomach Affects small intestine and colon Food or stool becomes stuck Can be life-threatening without treatment Symptoms: Severe abdominal pain and cramping Inability to pass gas or stool Severe bloating and distention Vomiting (may include fecal material) Loss of appetite Treatment: Often requires emergency hospitalization Nasogastric tube to decompress the stomach IV fluids and electrolytes Some cases require emergency surgery Risk of intestinal perforation or death if untreated Legal Claims: Patients who experienced bowel obstruction or ileus argue: This serious complication was not adequately disclosed Emergency room visits and surgeries could have been prevented Permanent bowel damage occurred Lost wages and medical bills are substantial Learn more about ileus warning signs and symptoms